<PAGE> 1
OMB APPROVAL
---------------------------
OMB Number: 3235-0145
Expires: December 31, 1997
Estimated average burden
hours per response...14.90
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 1)*
ICN Pharmaceuticals, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $.01 per share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
448924100
--------------------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement /X/. (A fee
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 4 pages
<PAGE> 2
CUSIP No. 448924100 13G Page 2 of 4 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
A I M Management Group Inc., on behalf of itself and its wholly-owned
subsidiaries, A I M Advisors, Inc. and A I M Capital Management, Inc.
I.D. No. 74-1881407
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) / /
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
State of Delaware
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
SHARES -------------------------------------------------
6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 3,555,221
------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
PERSON ------------------------------------------------
8 SHARED DISPOSITIVE POWER
WITH
3,555,221
- -------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,555,221
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
10.6%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
HC
- --------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
Page 2 of 4 pages
<PAGE> 3
SCHEDULE 13G
Item 1(a) NAME OF ISSUER:
ICN Pharmaceuticals, Inc.
Item 1(b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
3300 Hyland Avenue
Costa Mesa, CA 92626
Item 2(a) NAME OF PERSON FILING:
A I M Management Group Inc.
Item 2(b) ADDRESS OF PRINCIPAL BUSINESS OFFICE:
11 Greenway Plaza, Suite 1919
Houston, Texas 77046
Item 2(c) CITIZENSHIP:
State of Delaware
Item 2(d) TITLE OF CLASS OF SECURITIES:
Common Stock, par value $.01 per share
Item 2(e) CUSIP NUMBER:
448924100
Item 3 TYPE OF REPORTING PERSON:
Parent Holding Company, in accordance with section
240.13d-1(b)(ii)(G)
Item 4(a) AMOUNT BENEFICIALLY OWNED AS OF MAY 31, 1996:
3,555,221 shares of common stock
Item 4(b) PERCENT OF CLASS:
10.6%
Item 4(c) DEEMED VOTING POWER AND DISPOSITION POWER:
(i) sole power to vote or to direct
the vote: N/A
(ii) shared power to vote or to direct
the vote: 3,555,221
(iii) sole power to dispose or to direct
the disposition of: N/A
(iv) shared power to dispose or to direct
the disposition of: 3,555,221
Item 5 OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
N/A
Item 6 OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:
N/A
Page 3 of 4 pages
<PAGE> 4
Item 7 IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH
ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING
COMPANY:
A I M Advisors, Inc. and A I M Capital Management, Inc.,
Investment Advisers registered under Section 203 of the Investment
Advisers Act
Item 8 IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:
N/A
Item 9 NOTICE OF DISSOLUTION OF A GROUP:
N/A
Item 10 CERTIFICATION:
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were acquired in
the ordinary course of business and were not acquired for the
purpose of and do not have the effect of changing or
influencing the control of the issuer of such securities and
were not acquired in connection with or as a participant in
any transaction having such purposes or effect.
SIGNATURE:
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete and correct.
Date: June 10, 1996 A I M Management Group Inc.
/s/ CAROL F. RELIHAN
Carol F. Relihan
Vice President, Secretary and
General Counsel
Page 4 of 4 pages
